Multiple solutions for a class of fourth-order elliptic equations with critical growth
Open Mathematics · 25.04.2025 · 23 (1)
DOI: 10.1515/math-2025-0141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Mathematics, online erschienen am 25.04.2025. Verfasst von Guaiqi Tian und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this article, we study the semilinear biharmonic problem with a critical growth: Δ 2 u = μ Q ( x ) ∣ u ∣ p − 2 u + V ( x ) ∣ u ∣ 2 * * − 2 u in Ω , u = Δ u = 0 on ∂ Ω , \left\{\begin{array}{ll}{\Delta }^{2}u=\mu Q\left(x){| u| }^{p-2}u+V\left(x){| u| }^{{2}^{* * }-2}u\hspace{1.0em}& \hspace{0.1em}\text{in}\hspace{0.1em}\hspace{0.33em}\Omega ,\\ u=\Delta u=0\hspace{1.0em}& \hspace{0.1em}\text{on}\hspace{0.1em}\hspace{0.33em}\partial \Omega ,\end{array}\right. where Ω ⊂ R N ( N > 4 ) \Omega \subset {{\mathbb{R}}}^{N}\hspace{0.25em}\left(N\gt 4) is a smooth bounded domain, μ > 0 \mu \gt 0 , 1 < p < 2 1\lt p\lt 2 , and 2 * * = 2 N ⁄ ( N − 4 ) {2}^{* * }=2N/\left(N-4) is the critical Sobolev exponent. By using the Nehari method and the critical point theory, at least k k nontrivial solutions of the above equations for μ \mu sufficiently small and under some appropriate assumptions on Q Q and V V are obtained.
Zitieren
APA
Tian, G., Lei, J., & An, Y. (2025). Multiple solutions for a class of fourth-order elliptic equations with critical growth. Open Mathematics, 23(1). https://doi.org/10.1515/math-2025-0141
Vancouver
Tian G, Lei J, An Y. Multiple solutions for a class of fourth-order elliptic equations with critical growth. Open Mathematics. 2025;23(1). doi:10.1515/math-2025-0141
BibTeX
@article{Tian2025,
author = {Tian, Guaiqi and Lei, Jun and An, Yucheng},
title = {Multiple solutions for a class of fourth-order elliptic equations with critical growth},
journal = {Open Mathematics},
year = {2025},
volume = {23},
number = {1},
doi = {10.1515/math-2025-0141}
}
EUVIMED